News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aureon Laboratories Introduces Prostate Px(R)+, First Biopsy-Based Test to Predict Prostate Cancer Disease Progression and Recurrence


5/19/2008 8:54:12 AM

YONKERS, N.Y.--(BUSINESS WIRE)--Aureon Laboratories, Inc., a specialized laboratory dedicated to advancing personalized cancer treatment through predictive pathology, today announced the introduction of Prostate Px®+, the first commercial test to predict prostate cancer progression and disease recurrence at the time of diagnosis. The announcement was made at the American Urological Association Annual Meeting, now underway at the Orange County Convention Center in Orlando (Booth# 505).

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES